These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 696403)

  • 61. [Place of nuclear medicine methods in thyroid diagnosis].
    Studer H; König MP
    Schweiz Med Wochenschr; 1984 Mar; 114(11):361-4. PubMed ID: 6546807
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Unsuccessful radioiodine treatment of a non-toxic goiter: a case report.
    Hartoft-Nielsen ML; Rasmussen AK; Friis E; Blichert-Toft M; Buhl T; Hesse B; Feldt-Rasmussen U
    Basic Clin Pharmacol Toxicol; 2004 Aug; 95(2):72-5. PubMed ID: 15379783
    [TBL] [Abstract][Full Text] [Related]  

  • 63. An evaluation of the 24-hour RAIU test performed with an Anger camera and a pinhole collimator.
    Prince JR; Dukstein WG; White WE; Sullivan D
    Clin Nucl Med; 1979 Nov; 4(11):471-5. PubMed ID: 509847
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Iodine-123 SPECT of the thyroid in multinodular goiter.
    Chen JJ; LaFrance ND; Rippin R; Allo MD; Wagner HN
    J Nucl Med; 1988 Jan; 29(1):110-3. PubMed ID: 3257257
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Concurrent Plummer's disease and parathyroid adenoma. Diagnostic and therapeutic approaches to a difficult clinical problem.
    Geatti O; Proto G; Mazzolini A; Shapiro B; Orsolon PG; Guerra UP
    Clin Nucl Med; 1994 Jun; 19(6):508-11. PubMed ID: 8062469
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Thyroid volume and function after 131I treatment of diffuse non-toxic goitre.
    Nygaard B; Farber J; Veje A; Hansen JE
    Clin Endocrinol (Oxf); 1997 Apr; 46(4):493-6. PubMed ID: 9196613
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Radionuclide purity and radiation dosimetry of 124I used in positron tomography of the thyroid.
    Akbari RB; Ott RJ; Trott NG; Sharma HL; Smith AG
    Phys Med Biol; 1986 Jul; 31(7):789-91. PubMed ID: 3749264
    [No Abstract]   [Full Text] [Related]  

  • 68. [Treatment with (131)I of toxic multinodular goiter. Assessment of a fixed dose protocol].
    Abós MD; Banzo J; Razola P; García F; Prats E
    Rev Esp Med Nucl; 2000 Jun; 19(3):182-6. PubMed ID: 11062080
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Diagnotic value of 20 minute 99m Tc pertechnetate thyroid uptake.
    Höschl R; Gimlette TM
    Nucl Med (Stuttg); 1971; 10(4):305-15. PubMed ID: 5144930
    [No Abstract]   [Full Text] [Related]  

  • 70. [Radioiodine (131I) as the only treatment of hyperthyroidism. Results of 10 years of experience].
    Hennen G; McNamara EM; Dockier A; Joachim M
    Rev Med Liege; 1999 Jul; 54(7):611-7. PubMed ID: 10495684
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
    Berg GE; Michanek AM; Holmberg EC; Fink M
    J Nucl Med; 1996 Feb; 37(2):228-32. PubMed ID: 8667049
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Radioiodine for nontoxic multinodular goiter.
    Huysmans D; Hermus A; Edelbroek M; Barentsz J; Corstens F; Kloppenborg P
    Thyroid; 1997 Apr; 7(2):235-9. PubMed ID: 9133693
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Marked thyroid uptake of thallium-201 in patients with goiter: case report.
    Fukuchi M; Hyodo K; Tachibana K; Nishikawa A; Kido A; Nagai K
    J Nucl Med; 1977 Dec; 18(12):1199-201. PubMed ID: 606744
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Can radioactive iodine be used in the treatment of diffuse nontoxic goiter?].
    Harboe H
    Ugeskr Laeger; 1998 Dec; 160(51):7454-5. PubMed ID: 9889667
    [No Abstract]   [Full Text] [Related]  

  • 75. Hyperthyroidism after radiographic contrast in a patient with separate cervical and intrathoracic multinodular goiters.
    Breadmore R; McKenzie A; Arkles LB; Hicks RJ
    Clin Nucl Med; 1995 May; 20(5):413-5. PubMed ID: 7628143
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ultrasonographic thyroid volume as a reliable prognostic index of radioiodine-131 treatment outcome in Graves' disease hyperthyroidism.
    Gómez-Arnaiz N; Andía E; Gumà A; Abós R; Soler J; Gómez JM
    Horm Metab Res; 2003 Aug; 35(8):492-7. PubMed ID: 12953167
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The continuing impact of thyroid scintigraphy on the diagnosis of thyroid enlargement.
    Maxon HR; Hertzberg V; Vasavada P; Pu MY; Volarich D
    Clin Nucl Med; 1986 May; 11(5):306-7. PubMed ID: 3698425
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Intravenous or oral 131I treatment of hyperthyroidism and thyroid cancer?].
    Müller KD; Grebe SF; Bock FL; Müller H; Fängewisch GL
    Nuklearmedizin; 1994 Jun; 33(3):87-92. PubMed ID: 8090631
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Metabolic radiotherapy of hyperthyroidism].
    Salvatore M; Brunetti A
    Ann Ital Chir; 1989; 60(5):367-71. PubMed ID: 2699388
    [No Abstract]   [Full Text] [Related]  

  • 80. Four- to twenty-four-hour uptake ratio: an index of rapid iodine-131 turnover in hyperthyroidism.
    Aktay R; Rezai K; Seabold JE; Bar RS; Kirchner PT
    J Nucl Med; 1996 Nov; 37(11):1815-9. PubMed ID: 8917181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.